Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - DiaMedica Therapeutics Inc. | ex_231578.htm |
| EX-32.1 - EXHIBIT 32.1 - DiaMedica Therapeutics Inc. | ex_231577.htm |
| EX-31.2 - EXHIBIT 31.2 - DiaMedica Therapeutics Inc. | ex_231576.htm |
| EX-31.1 - EXHIBIT 31.1 - DiaMedica Therapeutics Inc. | ex_231575.htm |
| EX-4.1 - EXHIBIT 4.1 - DiaMedica Therapeutics Inc. | ex_232726.htm |
| 10-K - FORM 10-K - DiaMedica Therapeutics Inc. | dmtp20201231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-235775) and Form S-8 (File Nos. 333-228821 and 333-231717) of DiaMedica Therapeutics Inc. of our report dated March 10, 2021, relating to the consolidated financial statements of DiaMedica Therapeutics Inc., which appears in this annual report on Form 10-K for the fiscal year ended December 31, 2020.
/s/ Baker Tilly US, LLP
Minneapolis, Minnesota
March 10, 2021